Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

Research Site, Beijing

Research Site, Shenyang

Research Site, Harbin

Research Site, Suzhou

Research Site, Qingdao

Research Site, Hangzhou

Research Site, Taizhou

Research Site, Changsha

Research Site, Guangzhou

Research Site, Guangzhou

Research Site, Chengdu

Research Site, Chengdu

Research Site, Xi'an

Research Site, Xi'an

Research Site, Hohhot

Research Site, Zhuji